• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis - Product Image

The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis

  • ID: 1145627
  • December 2009
  • 81 Pages
  • GBI Research

FEATURED COMPANIES

  • AstraZeneca
  • GlaxoSmithKline (GSK)
  • Merck
  • Novartis
  • MORE

“The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis” provides in-depth analysis of unmet needs, drivers and barriers that impact the global respiratory diseases therapeutics market. The report analyzes the markets for respiratory disease therapeutics in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, price and volume are forecast until 2015 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and also analyzes the mergers, acquisitions and licensing agreements that shape the global markets.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts.

Scope

The scope of this report includes:

- Annualized market data for the respiratory diseases therapeutics market from 2000 to 2008, forecast forward to 2015

- Analysis of the leading therapeutic segments including asthma, chronic READ MORE >

FEATURED COMPANIES

  • AstraZeneca
  • GlaxoSmithKline (GSK)
  • Merck
  • Novartis
  • MORE

1 Contents
1.1 List of Tables
1.2 List of Figures

2 Global Respiratory Therapeutics Market : Scope of Research
2.1 Introduction
2.2 GBI Research Report Guidance

3 Global Respiratory Therapeutics Market : Market Characteraization
3.1 Market Forecasts
3.2 Branded Vs Generics
3.3 Average Cost of Therapy
3.4 Volume
3.5 Usage Patterns
3.5.1 Diseased Population
3.5.2 Treatment Seeking Population
3.5.3 Diagnosed Population
3.5.4 Prescription Population
3.5.5 Usage Patterns
3.5.6 Global Revenue Distribution Indication Wise

4 Global Asthma Therapeutics Market
4.1 Market Forecasts
4.2 Average Cost of Therapy
4.3 Volume
4.4 Usage Patterns
4.4.1 Diseased Population
4.4.2 Treatment Seeking Population
4.4.3 Diagnosed Population
4.4.4 Prescription Population
4.4.5 Usage Patterns

5 Global COPD Therapeutics Market
5.1 Market Forecasts
5.2 Average Cost of Therapy
5.3 Volume
5.4 Usage Patterns
5.4.1 Diseased Population
5.4.2 Treatment Seeking Population
5.4.3 Diagnosed Population
5.4.4 Prescription Population
5.4.5 Usage Patterns

6 Global Pulmonary Hypertension Therapeutics Market
6.1 Market Forecasts
6.2 Volume
6.3 Average Cost of Therapy
6.4 Usage Patterns
6.4.1 Diseased Population
6.4.2 Treatment Seeking Population
6.4.3 Diagnosed Population
6.4.4 Prescription Population
6.4.5 Usage Patterns

7 Global Cystic Fibrosis Therapeutics Market
7.1 Market Forecasts
7.2 Volume
7.3 Average Cost of Therapy
7.4 Usage Patterns
7.4.1 Diseased Population
7.4.2 Treatment Seeking Population
7.4.3 Diagnosed Population
7.4.4 Prescription Population
7.4.5 Usage Patterns

8 Global Respiratory Therapeutics Market : Market Drivers and Restraints
8.1 Market Drivers
8.1.1 Steady Increase in the Smoking Population
8.1.2 Stable Increase in Incidence Rates for Respiratory Diseases Disorders
8.1.3 Increase in Awareness Levels of Disease Progression and Etiology
8.2 Market Restraints
8.2.1 Patent Expirations and Entry of Generics Pose a Serious Problem for Primary Manufacturers
8.2.2 Reimbursement Restrictions on Drug Classes for Certain Respiratory Diseases Drug Classes Restricts the Market Growth
8.3 Global Respiratory Therapeutics Market: Unmet Needs
8.4 Global Respiratory Therapeutics Market: Key Market Trends
8.5 Increase in Disease Incidence and Prevalence Rates
8.6 Product Pipeline
8.7 Advertising and Commercialization
8.8 Regulatory Trends – Current Reimbursement Scenario
8.8.1 The Budget Impact on Drug Reimbursements
8.8.2 Reliability on Generic Formulations as a Cost Cutting Measure

9 Global Respiratory Therapeutics Market : Competitive Landscape
9.1 Overview
9.2 Market Share Analysis
9.3 Competitive Profiling
9.3.1 GlaxoSmithKline (GSK)
9.3.2 AstraZeneca
9.3.3 Merck
9.3.4 Novartis

10 Global Respiratory Therapeutics Market : Strategic Consolidations
10.1 Mergers and Acquisitions
10.1.1 Overview
10.2 Licensing Agreements
10.2.1 Approval
10.2.2 Filed
10.2.3 Phase III
10.2.4 Phase II
10.2.5 Pre-clinical
10.2.6 Discovery

11 Global Respiratory Therapeutics Market : Appendix
11.1 Market Definitions
11.2 Abbreviations
11.3 Research Methodology
11.3.1 Coverage
11.3.2 Secondary Research
11.3.3 Primary Research
11.3.4 Forecasts
11.3.5 Expert Panel Validation
11.4 Contact Us
11.5 Disclaimer

List of Tables:

Table 1: Global Respiratory Therapeutics Market, Historical Revenues ($m), 2000-2008
Table 2: Global Respiratory Therapeutics Market, Revenue Forecasts ($m), 2008-2015
Table 3: Global Respiratory Therapeutics Market, Revenue ($bn) Segmentation, 2000-2008
Table 4: Global Respiratory Therapeutics Market, Revenue Segmentation, 2008-2015
Table 5: Global Respiratory Therapeutics Market, Forecasts for Average Cost of Therapy ($), 2008-2015
Table 6: Global Respiratory Therapeutics Market, Historical Figures for Average Cost of Therapy ($), 2000-2008
Table 7: Global Respiratory Therapeutics Market, Historical Figures for Volume, 00-2008
Table 8: Global Respiratory Therapeutics Market, Forecasts for Volume, 2008-2015
Table 9: Global Respiratory Therapeutics Market, Historical Figures for Diseased Population, 2000-2008
Table 10: Global Respiratory Therapeutics Market, Forecasts for Diseased Population, 2008-2015
Table 11: Global Respiratory Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008
Table 12: Global Respiratory Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015
Table 13: Global Respiratory Therapeutics Market, Historical Figures for Diagnosed Population, 2000-2008
Table 14: Global Respiratory Therapeutics Market, Forecasts for Diagnosed Population, 2008-2015
Table 15: Global Respiratory Therapeutics Market, Historical Figures for Prescription Population, 2000-2008,
Table 16: Global Respiratory Therapeutics Market, Forecasts for Prescription Population, 2008-2015
Table 17: Global Respiratory Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008
Table 18: Global Respiratory Therapeutics Market, Forecasts for Usage Patterns, 2008-2015, November 2009
Table 19: Global Asthma Therapeutics Market, Historical Revenues ($bn), 2000-2008
Table 20: Global Asthma Therapeutics Market, Revenue Forecasts ($bn), 2008-2015
Table 21: Global Asthma Therapeutics Market, Historical Figures for the Average Cost of Therapy ($), 2000-2008
Table 22: Global Asthma Therapeutics Market, Forecast Figures for the Average Cost of Therapy ($), 2008-2015
Table 23: Global Asthma Therapeutics Market, Historical Figures for Volume, 2000-2008
Table 24: Global Asthma Therapeutics Market, Forecasts for Volume, 2008-2015, November 2009
Table 25: Global Asthma Therapeutics Market, Historical Figures for Diseased Population, 2000-2008
Table 26: Global Asthma Therapeutics Market, Forecasts for Diseased Population, 2008-2015
Table 27: Global Asthma Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008
Table 28: Global Asthma Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015
Table 29: Global Asthma Therapeutics Market, Historical Figures for Diagnosed Population, 2000-2008
Table 30: Global Asthma Therapeutics Market, Forecasts for Diagnosed Population, 2008-2015
Table 31: Global Asthma Therapeutics Market, Historical Figures for Prescription Population, 2000-2008
Table 32: Global Asthma Therapeutics Market, Forecasts for Prescription Population, 2008-2015
Table 33: Global Asthma Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008,
Table 34: Global Asthma Therapeutics Market, Forecasts for Usage Patterns, 2008-2015,
Table 35: Global COPD Therapeutics Market, Historical Revenues ($m), 2000-2008
Table 36: Global COPD Therapeutics Market, Revenue Forecasts ($m), 2008-2015
Table 37: Global COPD Therapeutics Market, Historical Figures for the Average Cost of Therapy ($), 2000-2008
Table 38: Global COPD Therapeutics Market, Forecast Figures for the Average Cost of Therapy ($), 2008-2015
Table 39: Global COPD Therapeutics Market, Historical Figures for Volume, 2000-2008, November 2009
Table 40: Global COPD Therapeutics Market, Forecasts for Volume, 2008-2015, November 2009
Table 41: Global COPD Therapeutics Market, Historical Figures for Diseased Population, 2000-2008
Table 42: Global COPD Therapeutics Market, Forecasts for Diseased Population, 2008-2015
Table 43: Global COPD Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008
Table 44: Global COPD Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015
Table 45: Global COPD Therapeutics Market, Historical Figures for Diagnosed Population, 2000-2008
Table 46: Global COPD Therapeutics Market, Forecasts for Diagnosed Population, 2008-2015, November 2009
Table 47: Global COPD Therapeutics Market, Historical Figures for Prescription Population, 2000-2008
Table 48: Global COPD Therapeutics Market, Forecasts for Prescription Population, 2008-2015
Table 49: Global COPD Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008
Table 50: Global COPD Therapeutics Market, Forecasts for Usage Patterns, 2008-2015
Table 51: Global Pulmonary Hypertension Therapeutics Market, Historical Revenues ($m), 2000-2008
Table 52: Global Pulmonary Hypertension Therapeutics Market, Revenue Forecasts ($m), 2008-2015
Table 53: Global Pulmonary Hypertension Therapeutics Market, Historical Figures for Volume, 2000-2008
Table 54: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Volume, 2008-2015
Table 55: Global Pulmonary Hypertension Therapeutics Market, Historical Figures for Average Cost of Therapy ($), 2000-2008
Table 56: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Average Cost of Therapy ($), 2008-2015
Table 57: Global Pulmonary Hypertension Therapeutics Market, Historical Figures for Diseased Population, 2000-2008
Table 58: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Diseased Population, 2008-2015
Table 59: Global Pulmonary Hypertension Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008
Table 60: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015
Table 61: Global Pulmonary Hypertension Therapeutics Market, Historical Figures for Diagnosed Population, 2000-2008
Table 62: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Diagnosed Population, 2008-2015
Table 63: Global Pulmonary Hypertension Therapeutics Market, Historical Figures for Prescription Population, 2000-2008
Table 64: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Prescription Population, 2008-2015
Table 65: Global Pulmonary Hypertension Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008
Table 66: Global Cystic Fibrosis Therapeutics Market, Historical Revenues ($m), 2000-2008
Table 67: Global Cystic Fibrosis Therapeutics Market, Revenue Forecasts ($m), 2008-2015
Table 68: Global Cystic Fibrosis Therapeutics Market, Historical Figures for Volume, 2000-2008
Table 69: Global Cystic Fibrosis Therapeutics Market, Forecasts for Volume, 2008-2015
Table 70: Global Cystic Fibrosis Therapeutics Market, Historical Figures for Average Cost of Therapy ($), 2000-2008
Table 71: Global Cystic Fibrosis Therapeutics Market, Forecasts for Average Cost of Therapy ($), 2008-2015
Table 72: Global Cystic Fibrosis Therapeutics Market, Historical Figures for Diseased Population, 2000-2008
Table 73: Global Cystic Fibrosis Therapeutics Market, Forecasts for Diseased Population, 2008-2015
Table 74: Global Cystic Fibrosis Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008
Table 75: Global Cystic Fibrosis Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015
Table 76: Global Cystic Fibrosis Therapeutics Market, Historical Figures for Diagnosed Population, 2000-2008
Table 77: Global Cystic Fibrosis Therapeutics Market, Forecasts for Diagnosed Population, 2008-2015
Table 78: Global Cystic Fibrosis Therapeutics Market, Historical Figures for Prescription Population, 2000-2008
Table 79: Global Cystic Fibrosis Therapeutics Market, Forecasts for Prescription Population, 2008-2015
Table 80: Global Cystic Fibrosis Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008
Table 81: Global Cystic Fibrosis Therapeutics Market, Forecasts for Usage Patterns, 2008-2015
Table 82: Global Respiratory Therapeutics Market, Market Drivers, 2008
Table 83: Global Respiratory Therapeutics Market, Major Drug Patent Expirations, 2008-2015
Table 84: Global Respiratory Therapeutics Market, Licensing Agreements for Approved Drugs, 2008-09
Table 85: Global Respiratory Therapeutics Market, Licensing Agreements for Drugs in the NDA/BLA Filed Stage, 2008-09
Table 86: Global Respiratory Therapeutics Market, Licensing Agreements for Drugs in the Phase III Stage, 2008-09
Table 87: Global Respiratory Therapeutics Market, Licensing Agreements for Drugs in the Phase II Stage, 2008-2009
Table 88: Global Respiratory Therapeutics Market, Licensing Agreements for Drugs in the Pre-Clinical Stage, 2008-2009, November 2009
Table 89: Global Respiratory Therapeutics Market, Licensing Agreements for Drugs in the Discovery Stage, 2008-2009, November 2009

List of Figures:

Figure 1: Global Respiratory Therapeutics Market, Revenue Forecasts ($m), 2000-2015
Figure 2: Global Respiratory Therapeutics Market, Revenue Segmentation, 2000-2015
Figure 3: Global Respiratory Therapeutics Market, Average Cost of Therapy ($), 2000-2015
Figure 4: Global Respiratory Therapeutics Market, Volume, 2000-2015
Figure 5: Global Respiratory Therapeutics Market, Diseased Population, 2000-2015
Figure 6: Global Respiratory Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015
Figure 7: Global Respiratory Therapeutics Market, Global Forecasts for Diagnosed Population, 2000-2015
Figure 8: Global Respiratory Therapeutics Market, Forecasts for Prescription Population, 2000-2015
Figure 9: Global Respiratory Therapeutics Market, Forecasts for Usage Patterns, 2000-2015,
Figure 10: Global Respiratory Therapeutics Market, , Revenue Distribution Indication Wise ($m), 2000-2015
Figure 11: Global Asthma Therapeutics Market, Revenue Forecasts ($m), 2000-2015
Figure 12: Global Asthma Therapeutics Market, Average Cost of Therapy ($), 2000-2015
Figure 13: Global Asthma Therapeutics Market, Volume, 2000-2015
Figure 14: Global Asthma Therapeutics Market, Forecasts for Diseased Population, 2000-2015
Figure 15: Global Asthma Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015
Figure 16: Global Asthma Therapeutics Market, Forecasts for Diagnosed Population, 2000-2015,
Figure 17: Global Asthma Therapeutics Market, Forecasts for Prescription Population, 2000-2015
Figure 18: Global Asthma Therapeutics Market, Forecasts for Usage Patterns, 2000-2015
Figure 19: Global COPD Therapeutics Market, Revenue Forecasts ($m), 2000-2015
Figure 20: Global COPD Therapeutics Market, Average Cost of Therapy ($), 2000-2015
Figure 21: Global COPD Therapeutics Market, Volume, 2000-2015
Figure 22: Global COPD Therapeutics Market, Forecasts for Diseased Population, 2000-2015
Figure 23: Global COPD Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015
Figure 24: Global COPD Therapeutics Market, Forecasts for Diagnosed Population, 2000-2015
Figure 25: Global COPD Therapeutics Market, Forecasts for Prescription Population, 2000-2015
Figure 26: Global COPD Therapeutics Market, Forecasts for Usage Patterns, 2000-2015
Figure 27: Global Pulmonary Hypertension Therapeutics Market, Revenue Forecasts ($m), 2000-2015
Figure 28: Global Pulmonary Hypertension Therapeutics Market, Volume, 2000-2015
Figure 29: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Average Cost of Therapy ($), 2000-2015
Figure 30: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Diseased Population, 2000-2015
Figure 31: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015
Figure 32: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Diagnosed Population, 2000-2015
Figure 33: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Prescription Population, 2000-2015
Figure 34: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Usage Patterns, 2000-2015
Figure 35: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Usage Patterns, 2008-2015
Figure 36: Global Cystic Fibrosis Therapeutics Market, Revenue Forecasts ($m), 2000-2015
Figure 37: Global Cystic Fibrosis Therapeutics Market, Volume, 2000-2015
Figure 38: Global Cystic Fibrosis Therapeutics Market, Forecasts for Average Cost of Therapy ($), 2000-2015
Figure 39: Global Cystic Fibrosis Therapeutics Market, Forecasts for Diseased Population, 2000-2015
Figure 40: Global Cystic Fibrosis Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015
Figure 41: Global Cystic Fibrosis Therapeutics Market, Forecasts for Diagnosed Population, 2000-2015
Figure 42: Global Cystic Fibrosis Therapeutics Market, Forecasts for Prescription Population, 2000-2015
Figure 43: Global Cystic Fibrosis Therapeutics Market, Forecasts for Usage Patterns, 2000-2015
Figure 44: Global Respiratory Therapeutics Market, Market Indicators, 2008, November 2009
Figure 45: Global Respiratory Therapeutics Market, Market Restraints, 2008
Figure 46: Global Respiratory Therapeutics Market, Analysis of Unmet Needs for Major Disease Sectors, 2008
Figure 47: Global Respiratory Therapeutics Market, Key Market Events, 2008-2015
Figure 48: Global Respiratory Therapeutics Market, Market Share of Top Manufacturers, 2008
Figure 49: Respiratory Therapeutics Market, Global Benchmarking Analysis for the Top Four Manufacturers, 2008
Figure 50: Respiratory Therapeutics Market, Global Benchmarking Analysis for the Top Four Manufacturers (Cont..), 2008
Figure 51: Global Respiratory Therapeutics Market, M&A Deals by Geography, 2008
Figure 52: Global Respiratory Therapeutics Market, M&A Deals by Deal Size, 2008
Figure 53: Global Respiratory Therapeutics Market, M&A Deals by Phase, 2008
Figure 54: Global Respiratory Therapeutics Market, Top Three M&A Deals, 2008
Figure 55: Global Respiratory Therapeutics Market, Licensing Agreements by Geography, 2008
Figure 56: Global Respiratory Therapeutics Market, Licensing Agreements by Deal Size, 2008
Figure 57: Global Respiratory Therapeutics Market, Licensing Agreements by Phases of Development, 2008
Figure 58: Global Respiratory Therapeutics Market, Licensing Agreements by Indications, 2008, November 2009
Figure 59: GBI Research Methodology
Figure 60: Global Respiratory Therapeutics Market Forecasting Model

FEATURED COMPANIES

  • AstraZeneca
  • GlaxoSmithKline (GSK)
  • Merck
  • Novartis
  • MORE

“The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis” essentially provides insights on the respiratory market’s potential, actual sales, actual volume and price forecasts to 2015. The report also delves deep into the respiratory market potential in various indications such as pulmonary hypertension, cystic fibrosis, asthma, and Chronic Obstructive Pulmonary Disease (COPD), and provides insights into the respiratory disease R&D pipeline. The report also elucidates the respiratory disease’s competitive landscape including the benchmarking of leading companies. Finally, key trend analysis on mergers and acquisitions, and licensing agreements involving respiratory disease therapeutics are also provided.

Patent Expiries Coupled with Generic Competition are Negatively Impacting the Market Pulling it down to CAGR 2.8% in 2009-2015 from CAGR 11%in 2000-2008.

The Global Respiratory Therapeutics market was valued to be worth $20.1 billion in 2008 and is expected to rise in revenues to $24.5 billion with a Compound Annual Growth Rate (CAGR) of 2.8% by 2015. In 2008, approximately 23.5 million patients received pharmacological treatment for their respiratory diseases with the average cost of therapy being $4,160 per year. The patient volume appears to be increasing at a significant rate of 5% per year. In addition, the average annual cost of therapy for the respiratory diseases therapeutic area appears to be increasing at a gradual rate over the next one year with an expected slight price decline from 2010 onwards. As a result, the respiratory disease market growth rate is going to see a decline during 2008 – 2015.

High Unmet Need across all Indications of Respiratory Therapeutic Market.

Respiratory disease disorders such as asthma and COPD are currently some of the most explored therapeutic areas while cystic fibrosis and pulmonary hypertension are some of the least explored. The market consists of several drugs with high safety levels. The cystic fibrosis market and pulmonary hypertension is in need of an effective replacement for current therapy to streamline long-term treatment.

Top Five Companies Contributed to 48% of the Global Sales in 2008.

GlaxoSmithKline (GSK) is the market leader with 21% market share which accounted for $8.3 billion in 2008 of the respiratory therapeutics sector. Merck, with an approximate market share of 12%, accounted for $4.9 billion to the market. Astrazeneca contributed approximately $3.8bn to the market cutting a share of approximately 10%. Novartis holds a market share of 3%. Other major players within the market included Sanofi-Aventis and Sepracor which contributed approximately 3% of the respiratory therapeutics market.

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos